Form 4: LeMaitre Vascular CEO Exercises Stock Options

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, exercised options to acquire 2,681 shares of common stock at $41.02 per share.

Summary

• George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., acquired 2,681 shares of common stock.
• The acquisition occurred on November 20, 2025, through the exercise of stock options.
• The exercise price for these shares was $41.02 per share.
• Following this transaction, Mr. LeMaitre directly beneficially owns 1,665,984 shares of common stock.
• Additionally, 21,300 shares are indirectly held by the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 for the benefit of his child(ren).
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• The exercised option was fully vested and exercisable, originally granted on December 2, 2020, and set to expire on December 2, 2025.

Sentiment

Score: 5

Explanation: A routine option exercise by an insider, especially under a 10b5-1 plan, is generally neutral. It reflects the executive's compensation structure and equity management rather than a strong bullish or bearish signal.

Positives

• The CEO exercised options, indicating a potential belief in the company's future value as he is acquiring shares.
• The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned, non-discretionary transaction.

Risks

• The Limited Power of Attorney includes an indemnification clause where the undersigned agrees to indemnify the attorneys-in-fact and the Company from any demand, damage, loss, cost, or expense arising from any false or misleading information provided by the undersigned to the attorneys-in-fact. This highlights the risk of inaccurate information being provided by the reporting person.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This routine insider transaction, an option exercise by the CEO, does not provide specific insights into broader industry trends or competitive dynamics. It primarily reflects an individual's compensation and equity management strategy within the medical device sector.

Corporate Governance

Related Party Transactions

• 21,300 shares are indirectly held by the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 for the benefit of the Reporting Person's child(ren). The Reporting Person disclaims ownership except to the extent of pecuniary interest.

Stakeholder Impact

• Shareholders: The transaction is a routine insider option exercise, which typically has minimal direct impact on existing shareholders. It provides transparency regarding executive equity holdings.
• Management/Employees: Reflects the exercise of executive compensation, which is part of the overall compensation structure for key personnel.

Key Dates

Recommendation

This Form 4 filing reports a routine exercise of stock options by the CEO under a pre-arranged 10b5-1 plan. Such a transaction is generally expected and does not provide new fundamental information about the company's performance or future prospects that would warrant a change in investment recommendation. It primarily reflects the executive's compensation structure and personal equity management.

Keywords

LeMaitre Vascular, LMAT, SEC Form 4, Insider Trading, Stock Options, CEO, Beneficial Ownership, Equity Compensation, Rule 10b5-1